Research progress on application of simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma
10.3760/cma.j.cn113030-20210120-00035
- VernacularTitle:同期整合加量调强放疗在食管癌中的应用进展
- Author:
Lan WANG
1
;
Yamin WANG
;
Lihong LIU
;
Shutang LIU
;
Chun HAN
;
Jinming YU
Author Information
1. 河北医科大学第四医院放疗科，石家庄 050011
- Keywords:
Esophageal neoplasm/intensity-modulated radiotherapy;
Simultaneous integrated boost;
Application progress
- From:
Chinese Journal of Radiation Oncology
2021;30(11):1216-1220
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, unconventional fractionated radiotherapy has shown increasing advantages in the treatment of multiple system tumors. Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) involves the delivery of standard-fraction doses of radiotherapy to different areas, achieving the delivery of higher doses of radiotherapy per fraction to the high-risk gross tumor volume (GTV) without sacrificing the irradiation dose to the normal tissues. The dosimetric advantages of SIB-IMRT have been widely recognized. At present, the local control, survival advantage, indication population and the optimal upper limit of single fraction of SIB-IMRT for esophageal carcinoma are still unclear. This article reviews the application of SIB-IMRT in esophageal carcinoma.
